https://www.cochranelibrary.com/web/cochrane/content?templateType=full&urlTitle=/cdsr/doi/10.1002/14651858.CD015395.pub3&doi=10.1002/14651858.CD015395.pub3&type=cdsr&contentLanguage=&highlightAbstract=paxlovid
Lots of criticism levelled at Starpharma for not conducting human placebo trials. But in January we got a great significant human covid treatment trial. I think this report by Cochrane Org about Paxlovid changes perspective and one really questions how TGA meekly followed FDA and gave TA temporary approval to Pfizer. Cochrane seems very unimpressed
If Viraleze 7 day treatment is competing with Paxlovid - who wins
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $55.62M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $18.55K | 139.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 138865 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 86448 | 5 |
View Market Depth
| Last trade - 16.10pm 26/04/2024 (20 minute delay) ? |
|
|||||
|
Last
13.5¢ |
Change
0.000 ( 3.85 %) |
||||
| Open | High | Low | Volume | ||
| 13.5¢ | 13.5¢ | 13.0¢ | 6144 | ||
| Last updated 15.59pm 26/04/2024 ? | |||||
| SPL (ASX) Chart |